Neovascular AMD with marked macular fluid and rapid response to anti-VEGF therapy. –

PubMed ID: 24512809

Author(s): Wood E, Chang JS, Flynn HW Jr, Kitchens JW. Neovascular AMD with marked macular fluid and rapid response to anti-VEGF therapy. Ophthalmic Surg Lasers Imaging Retina. 2014 Mar-Apr;45(2):175-8. doi: 10.3928/23258160-20140205-02. Epub 2014 Feb 10. PMID 24512809

Journal: Ophthalmic Surgery, Lasers & Imaging Retina, Volume 45, Issue 2, 2014

The authors describe the clinical management and spectral-domain optical coherence tomography (SD-OCT) findings of three unusual cases of neovascular age-related macular degeneration (AMD). Each patient presented with decreased vision and a diagnosis of neovascular AMD, with SD-OCT findings of marked macular fluid. Macular fluid was noted to be subretinal fluid, pigment epithelial detachment, or both. In each case, visual acuity improved and the fluid resolved rapidly with monthly anti-vascular endothelial growth factor therapy.